Learning from our immunological history: What can SARS-CoV teach us about SARS-CoV-2?

Henrickson, Sarah E

Henrickson, Sarah E.

Henrickson SE; Children's Hospital of Pediatrics, Division of Allergy Immunology, Philadelphia, PA 19104, USA. Email: henricksons@email.chop.edu.

Sci Immunol ; 5(46)2020 04 03.

Article in English | MEDLINE | ID: covidwho-34175

ABSTRACT

ABSTRACT

Many strategies are being deployed to rapidly uncover targetable mechanisms of infection for SARS-CoV-2, and Hoffman et al exploit our understanding and immunological experience with SARS-CoV in our global race to understand, mitigate, and eventually prevent COVID-19.

Subject(s)

Betacoronavirus; Coronavirus Infections/prevention & control; Pandemics/prevention & control; Peptidyl-Dipeptidase A/metabolism; Pneumonia, Viral/prevention & control; Spike Glycoprotein, Coronavirus/antagonists & inhibitors; Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing/pharmacology; Antibodies, Viral/pharmacology; COVID-19; Cell Line; Esters; Gabexate/analogs & derivatives; Gabexate/pharmacology; Guanidines; Humans; Rabbits; Severe acute respiratory syndrome-related coronavirus; SARS-CoV-2; Serine Endopeptidases/metabolism; Serine Proteinase Inhibitors/pharmacology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Peptidyl-Dipeptidase A / Pandemics / Spike Glycoprotein, Coronavirus / Betacoronavirus Type of study: Prognostic study Limits: Animals / Humans Language: English Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google